These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 22965775

  • 1. Penile alterations with severe sperm abnormalities in antiphospholipid syndrome associated with systemic lupus erythematosus.
    Rabelo-Júnior CN, Bonfá E, Carvalho JF, Cocuzza M, Saito O, Abdo CH, Silva CA.
    Clin Rheumatol; 2013 Jan; 32(1):109-13. PubMed ID: 22965775
    [Abstract] [Full Text] [Related]

  • 2. Primary antiphospholipid syndrome: morphofunctional penile abnormalities with normal sperm analysis.
    Rabelo-Júnior CN, Freire de Carvalho J, Lopes Gallinaro A, Bonfá E, Cocuzza M, Saito O, Silva CA.
    Lupus; 2012 Mar; 21(3):251-6. PubMed ID: 22004973
    [Abstract] [Full Text] [Related]

  • 3. Penile anthropometry in systemic lupus erythematosus patients.
    Vecchi AP, Borba EF, Bonfá E, Cocuzza M, Pieri P, Kim CA, Silva CA.
    Lupus; 2011 Apr; 20(5):512-8. PubMed ID: 21282296
    [Abstract] [Full Text] [Related]

  • 4. Complete urological evaluation including sperm DNA fragmentation in male systemic lupus erythematosus patients.
    Tiseo BC, Bonfá E, Borba EF, Munhoz GA, Wood G, Srougi M, Silva CA, Cocuzza M.
    Lupus; 2019 Jan; 28(1):59-65. PubMed ID: 30509155
    [Abstract] [Full Text] [Related]

  • 5. Testicular Sertoli cell function in male systemic lupus erythematosus.
    Suehiro RM, Borba EF, Bonfa E, Okay TS, Cocuzza M, Soares PM, Silva CA.
    Rheumatology (Oxford); 2008 Nov; 47(11):1692-7. PubMed ID: 18786967
    [Abstract] [Full Text] [Related]

  • 6. Effect of ethnicity on clinical presentation and risk of antiphospholipid syndrome in Roma and Caucasian patients with systemic lupus erythematosus: a multicenter cross-sectional study.
    Manzano-Gamero V, Pardo-Cabello AJ, Vargas-Hitos JA, Zamora-Pasadas M, Navarrete-Navarrete N, Sabio JM, Jáimez-Gámiz L, Ríos-Fernandez R, Ortego-Centeno N, Ayala-Gutierrez MM, de Ramón E, Colodro-Ruíz A, Micó-Giner L, Castillo-Palma MJ, Robles-Marhuenda Á, Luna-Del Castillo JD, Jiménez-Alonso J, Spanish Autoimmune Diseases Study Group (GEAS).
    Int J Rheum Dis; 2018 Nov; 21(11):2028-2035. PubMed ID: 28593703
    [Abstract] [Full Text] [Related]

  • 7. Gonad evaluation in male systemic lupus erythematosus.
    Soares PM, Borba EF, Bonfa E, Hallak J, Corrêa AL, Silva CA.
    Arthritis Rheum; 2007 Jul; 56(7):2352-61. PubMed ID: 17599762
    [Abstract] [Full Text] [Related]

  • 8. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A, de Azevedo MN, de Souza Papi JA, Petri M.
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [Abstract] [Full Text] [Related]

  • 9. Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus.
    Perez-Sanchez C, Barbarroja N, Messineo S, Ruiz-Limon P, Rodriguez-Ariza A, Jimenez-Gomez Y, Khamashta MA, Collantes-Estevez E, Cuadrado MJ, Aguirre MA, Lopez-Pedrera C.
    Ann Rheum Dis; 2015 Jul; 74(7):1441-9. PubMed ID: 24618261
    [Abstract] [Full Text] [Related]

  • 10. Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients.
    Ramos-Casals M, Campoamor MT, Chamorro A, Salvador G, Segura S, Botero JC, Yagüe J, Cervera R, Ingelmo M, Font J.
    Lupus; 2004 Jul; 13(10):777-83. PubMed ID: 15540510
    [Abstract] [Full Text] [Related]

  • 11. Histological features of antiphospholipid nephropathy in patients with Systemic Lupus Erythematosus.
    Naseeb F, Arfaj AA, Hamdani A, Kfoury H, Parvez K, Mogairen SA.
    J Coll Physicians Surg Pak; 2015 May; 25(5):332-6. PubMed ID: 26008657
    [Abstract] [Full Text] [Related]

  • 12. Double heterozygosity polymorphisms for platelet glycoproteins Ia/IIa and IIb/IIIa increases arterial thrombosis and arteriosclerosis in patients with the antiphospholipid syndrome or with systemic lupus erythematosus.
    Jiménez S, Tàssies D, Espinosa G, García-Criado A, Plaza J, Monteagudo J, Cervera R, Reverter JC.
    Ann Rheum Dis; 2008 Jun; 67(6):835-40. PubMed ID: 17728329
    [Abstract] [Full Text] [Related]

  • 13. Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality.
    Riancho-Zarrabeitia L, Martínez-Taboada V, Rúa-Figueroa I, Alonso F, Galindo-Izquierdo M, Ovalles J, Olivé-Marqués A, Fernández-Nebro A, Calvo-Alén J, Menor-Almagro R, Tomero-Muriel E, Uriarte-Isacelaya E, Botenau A, Andres M, Freire-González M, Santos Soler G, Ruiz-Lucea E, Ibáñez-Barceló M, Castellví I, Galisteo C, Quevedo Vila V, Raya E, Narváez-García J, Expósito L, Hernández-Beriaín JA, Horcada L, Aurrecoechea E, Pego-Reigosa JM.
    Lupus; 2020 Oct; 29(12):1556-1565. PubMed ID: 32807021
    [Abstract] [Full Text] [Related]

  • 14. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [Abstract] [Full Text] [Related]

  • 15. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U, Yayla ME, Ateş A, Okatan İE, Yurteri EU, Torgutalp M, Keleşoğlu ABD, Turgay TM, Kınıklı G.
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [Abstract] [Full Text] [Related]

  • 16. Clinical manifestations and antiphosphatidylserine antibodies in patients with systemic lupus erythematosus: is there an association?
    Sahin M, Duzgun N, Tunc SE, Tutkak H.
    Clin Rheumatol; 2007 Feb; 26(2):154-60. PubMed ID: 16598413
    [Abstract] [Full Text] [Related]

  • 17. Markers of NETosis in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome.
    Reshetnyak T, Nurbaeva K, Ptashnik I, Kudriaeva A, Belogurov A, Lila A, Nasonov E.
    Int J Mol Sci; 2023 May 24; 24(11):. PubMed ID: 37298160
    [Abstract] [Full Text] [Related]

  • 18. Antiphospholipid syndrome damage index (DIAPS): distinct long-term kinetic in primary antiphospholipid syndrome and antiphospholipid syndrome related to systemic lupus erythematosus.
    Torricelli AK, Ugolini-Lopes MR, Bonfá E, Andrade D.
    Lupus; 2020 Mar 24; 29(3):256-262. PubMed ID: 31986962
    [Abstract] [Full Text] [Related]

  • 19. Extended Antiphospholipid Antibodies Screening in Systemic Lupus Erythematosus Patients.
    Dima A, Caraiola S, Jurcut C, Balanescu E, Balanescu P, Ramba D, Badea C, Pompilian V, Ionescu R, Baicus A, Baicus C, Dan GA.
    Rom J Intern Med; 2015 Mar 24; 53(4):321-8. PubMed ID: 26939208
    [Abstract] [Full Text] [Related]

  • 20. Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Jiménez S, García-Criado MA, Tàssies D, Reverter JC, Cervera R, Gilabert MR, Zambón D, Ros E, Bru C, Font J.
    Rheumatology (Oxford); 2005 Jun 24; 44(6):756-61. PubMed ID: 15757967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.